「the first」の検索結果
22件：1～5件目を表示
-
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical tr...
http://www.senju.co.jp/english/rd/trial.html -
临床试验信息 | 研究与开发 | 千寿制药株式会社
clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical tr...
http://www.senju.co.jp/chinese/rd/trial.html -
产品开发方针 | 研究与开发 | 千寿制药株式会社
发，从而为患者带去希望。 #1: 井上 佐智子, 川岛 素子, 坪田 一男：什么是干眼症？从原因到最新的治疗，Farumashia，2014 50(3): 201-6 #2: Papas EB. The global prevalence of dry eye disease: A Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254-6...
http://www.senju.co.jp/chinese/rd/policy/ -
Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical
The success of our premier line of ophthalmological drugs has launched our entry into other promising fields of medicine Senju Pharmaceutical greatly values the clinical experience of medical professi...
https://www.senju.co.jp/english/about/business/mp.html -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
開発に挑戦し続けています。 #1:井上 佐智子, 川島 素子, 坪田 一男：ドライアイとは？原因から最新の治療まで、ファルマシア, 2014 50(3): 201-6 #2: Papas EB. The global prevalence of dry eye disease: A Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254-6...
https://www.senju.co.jp/rd/policy/